心脉医疗:24H2承压明显,看好海外收入增长
Endovastec(688016) 华安证券·2024-11-21 07:35
心脉[Table_StockNameRptType] 医疗(688016) 公司点评 24H2 承压明显,看好海外收入增长 | --- | --- | --- | --- | --- | --- | --- | --- | |---------------------------------------------------------------------------------------------------------------------------------------------|---------------|----------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------- ...